| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996789 | Practical Radiation Oncology | 2013 | 7 Pages |
Abstract
Clinical follow-up for local lung tumor control in a sizable cohort of patients treated with SABR demonstrates that EPL overestimates dose by amounts that substantially decrease TCP in a large proportion. EPL algorithms should be avoided for lung tumor SABR.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Michael B. MS, Neville C.W. BS, Nicholas MD, PhD, James MD, MA, Maximilian MD, PhD, Quynh-Thu MD, Sonja PhD, Peter G. PhD, Billy W. MD, PhD,